View in EDS PDF Full Text

Monitoring of Disease in Patients Receiving 177LU-PSMA-617 Therapy in Routine Practice.

Saved in:
Bibliographic Details
Title: Monitoring of Disease in Patients Receiving 177LU-PSMA-617 Therapy in Routine Practice.
Authors: Rashid NS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Zhong C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Xie W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Stoltenberg H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wolanski A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ritzer J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Jacene H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Nuclear Medicine, Brigham & Women's Hospital, Boston, MA., Ravi P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: praful_ravi@dfci.harvard.edu.
Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2026 Jun; Vol. 24 (4), pp. 102532. Date of Electronic Publication: 2026 Mar 02.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0682
DOI:10.1016/j.clgc.2026.102532